MilliporeSigma Expands Popular Line of Guava® Flow Cytometers

Billerica, Massachusetts, May 11, 2016 – MilliporeSigma today announced it has expanded its popular line of Guava® flow cytometers to include a high-power modulated green laser...

11 May 2016 | Billerica, Massachusetts, United States of America
  • Optical configurations meet needs of any lab, research discipline or individual application
  • Product can detect up to 14 parameters from a single sample

Billerica, Massachusetts, May 11, 2016 – MilliporeSigma today announced it has expanded its popular line of Guava® flow cytometers to include a high-power modulated green laser.

The addition of a 532 nanometer laser expands the detection capabilities of the Guava® easyCyte instrument line to enable simultaneous detection of multiple fluorescent proteins. It also offers researchers more spectral choice using fluorescent reagents. More powerful violet, blue and red lasers are now standard in most configurations, meaning the Guava® cytometers are sensitive enough to detect subcellular particles as small as viruses.

Since the discovery and isolation of the genes encoding proteins responsible for biological fluorescence, fluorescent proteins (FPs) have changed life science research. Both mutation of the original green FP and discovery of naturally occurring proteins emitting elsewhere in the spectrum have resulted in FPs of many colors. The company’s new Guava® easyCyte green laser variants meet the need for instrumentation that allows users to analyze heterogeneous biological tissues and systems in a single experiment.

MilliporeSigma’s Guava® pioneered microfluidics in flow cytometry 15 years ago when the company introduced the first benchtop flow cytometers. This new enhanced optical capability and flexibility has been achieved by Guava® engineers with no increase in instrument size and without sacrificing affordability. Better optical configurations that allow for more meaningful analysis permit a small benchtop footprint. This gives users reduced buffer and sample volumes and dramatically reduces waste when compared with sheath-based flow cytometers.


For more information, contact Karen Tiano

All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Related News

  1. Press Releases

    Michael Kleinemeier Chairman of our Supervisory Board until the 2024 AGM

    Our Supervisory Board has elected Michael Kleinemeier (66) as its Chairman. He was Member of the SAP SE Executive Board from 2015 to 2020.